✦ LIBER ✦
1006 ORAL Prognostic Factors for Progression-free Survival (PFS), Overall Survival (OS), and Long-term OS (LT-OS) With Sunitinib in 1,059 Patients, Treated on Clinical Trials, With Metastatic Renal Cell Carcinoma (mRCC)
✍ Scribed by R.J. Motzer; B. Escudier; R. Bukowski; B.I. Rini; T.E. Hutson; C.H. Barrios; X. Lin; K. Fly; E. Matczak; M.E. Gore
- Book ID
- 117661145
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 61 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.